Cross-Sector entity
Every one of those 1 sits in a single category, pharma. Of the tracked stories, 1 of 1 also mention ASEAN, the most common co-covered peer. Each carries 2 original sources on average. We currently track 1 Cross-Sector story that mention Plasma-Derived Medicinal Products (PDMPs), all published on July 13, 2026.
1 verified story tracked
Last mentioned: Jul 13, 2026
Entity pulse
Coverage balance Positive coverage leads. Positive coverage exceeds negative coverage by 100 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
Every one of those 1 sits in a single category, pharma. Of the tracked stories, 1 of 1 also mention ASEAN, the most common co-covered peer. Each carries 2 original sources on average. We currently track 1 Cross-Sector story that mention Plasma-Derived Medicinal Products (PDMPs), all published on July 13, 2026.
Computed from the 1 stories linked to this entity. Beat comparisons are omitted because no baseline was available for this window.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Plasma-Derived Medicinal Products (PDMPs). Shared-story counts are live from our verified record — not editorial picks.
Takeda receives Indonesia’s first plasma fractionation license, part of a $30 million collaboration to build a domestic plasma ecosystem. The initiative aims to scale manufacturing of plasma-derived medicinal products, positioning Indonesia as a regional biopharma hub.
Source: Business Wire (ca) · Business Wire (ca)
